Filing Details
- Accession Number:
- 0001209191-20-039272
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-29 20:13:05
- Reporting Period:
- 2020-06-25
- Accepted Time:
- 2020-06-29 20:13:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1419041 | Forte Biosciences Inc. | FBRX | Pharmaceutical Preparations (2834) | 261243872 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1612842 | A. Paul Wagner | C/O Forte Biosciences, Inc. 1124 W. Carson Street, Mrl Bldg. 3-320 Torrance CA 90502 | See Remarks | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-06-25 | 7,000 | $14.48 | 2,279,049 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 7,000 shares purchased in the price range of $14.1620 to $14.9899 by the Reporting Person. The Reporting Person undertakes to provide upon requestby the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
